Apoptosis of myocytes and proliferation markers as prognostic factors in end-stage dilated cardiomyopathy

Cardiovascular Pathology

Volumn 12, Issue 1, 2003, Pages 36-39

  Zorc, Marjeta ^a   Vraspir Porenta, Olga ^a   Zorc Pleskovič, Ruda ^a   Radovanović, Ninoslav ^b   Petrovič, Daniel ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b Clinique Cecil   (Switzerland)

Author keywords

Apoptosis; Morphometry; Myocytes; Myofibril volume fraction; Prognostic marker; Proliferation; Volume density of interstitial tissue

Indexed keywords

BIOLOGICAL MARKER; CYCLINE; KI 67 ANTIGEN; PROTEIN BCL 2;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL VOLUME; CONTROLLED STUDY; FEMALE; HEART DILATATION; HEART FAILURE; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HEART VOLUME; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERSTITIUM; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; MORTALITY; MUSCLE FIBRIL; MUSCLE MASS; NICK END LABELING; OPEN HEART SURGERY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; APOPTOSIS; BIOLOGICAL MARKERS; BIOPSY; CARDIOMYOPATHY, DILATED; CELL DIVISION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KI-67 ANTIGEN; MALE; MIDDLE AGED; MYOCARDIUM; MYOCYTES, CARDIAC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0037276292     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1054-8807(02)00134-5     Document Type: Article

References (18)

1. Anversa P., Kajstura I., Olivetti G. Myocyte death in heart failure. Curr Opin Cardiol. 11:1996;245-251.
2. Olivetti G., Abbi R., Quaini Fet al. Apoptosis in the failing human heart. N Engl J Med. 336:1997;1131-1141.
3. Miyashita T., Harigai M., Hanada Met al. Identification of p53 dependent negative response element in the Bcl-2 gene. Cancer Res. 54:1994;3131-3135.
4. Gallo P., d'Amati G., Pelliccia F., Bernucci P., Cianfrocca C., Marino B. Functional significance of myocellular hypertrophy in dilated cardiomyopathy: histomorphometric analysis on 40 endomyocardial biopsies. Am J Cardiovasc Pathol. 5:1995;11-18.
5. Pelliccia F., d'Amati G., Cianfrocca Cet al. Histomorphometric features predict 1-year outcome of patients with idiopathic dilated cardiomyopathy considered to be at low priority for cardiac transplantation. Am Heart J. 128:1994;316-325.
6. Beltrami C.A., Finato N., Rocco Met al. The cellular basis of dilated cardiomyopathy in humans. J Mol Cell Cardiol. 27:1995;291-305.
7. Schwarz F., Mall G., Zebe Het al. Quantitative morphologic findings of the myocardium in idiopathic dilated cardiomyopathy. Am J Cardiol. 51:1983;501-506.
8. Arbustini E., Diegoli M., Grasso Met al. Expression of proliferation markers in normal and diseased human heart. Am J Cardiol. 72:1993;608-614.
9. Marino T.A., Haldar S., Williamson ECet al. Proliferation cell nuclear antigen in the developing and adult cardiac muscle cells. Circ Res. 69:1991;1353-1360.
10. Jaskulski D., Gatti C., Travali S., Calabretta B., Baserga R. Regulation of the proliferating cell nuclear antigen cyclin and thymidine kinase mRNA levels by growth factors. J Biol Chem. 25(263):1988;10175-10179.
11. Radovanovic N., Mihajlovic B., Selestiansky Jet al. Reductive annuloplasty of double orifices in patients with primary dilated cardiomyopathy. Ann Thorac Surg. 73:2002;751-755.
12. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation. 93:1996;841-842.
13. Petrovič D., Zorc-Pleskovič R., Zorc M. Apoptosis and proliferation of cardiomyocytes in heart failure of different etiologies. Cardiovasc Pathol. 9:2000;149-152.
14. Weibel E.R. Practical methods for biological morphometry. Stereological methods. 1979;Academic Press, London.
15. Narula J., Haider N., Virmani Ret al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 335:1996;1182-1189.
16. Figulla H.R., Rahlf G., Nieger M. Spontaneous haemodynamic improvement or stabilization and associated biopsy findings in patients with congestive cardiomyopathy. Circulation. 71:1985;1095-1104.
17. Beltrami A.P., Urbanek K., Kajstura Jet al. Evidence that human cardiac myocyte divide after myocardial infarction. N Engl J Med. 344:2001;1750-1757.
18. Kajstura J., Leri A., Finato N., Di Loreto C., Beltrami C.A., Anversa P. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci USA. 95:1998;8801-8805.